Intensity-Modulated Arc Therapy with Simultaneous Integrated Boost in the Treatment of Primary Irresectable Cervical Cancer

[1]  Richard Pötter,et al.  MRI Assessment of Cervical Cancer for Adaptive Radiotherapy , 2009, Strahlentherapie und Onkologie.

[2]  V. Nagy,et al.  Radiotherapy versus Concurrent 5-Day Cisplatin and Radiotherapy in Locally Advanced Cervical Carcinoma , 2009, Strahlentherapie und Onkologie.

[3]  P. Georg,et al.  Assessment of Improved Organ at Risk Sparing for Advanced Cervix Carcinoma Utilizing Precision Radiotherapy Techniques , 2008, Strahlentherapie und Onkologie.

[4]  H. Christiansen,et al.  An Easy Irradiation Technique (Partial Half-Beam) to Reduce Renal Dose in Radiotherapy of Cervical Cancer Including Paraaortic Lymph Nodes , 2008, Strahlentherapie und Onkologie.

[5]  B. Esterni,et al.  Equivalent survival in patients with advanced stage IB-II and III-IVA cervical cancer treated by adjuvant surgery following chemoradiotherapy. , 2008, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[6]  J. Dimopoulos,et al.  Preliminary Results of a Comparison between High-tech External Beam and High-tech Brachytherapy for Cervix Carcinoma , 2007, Strahlentherapie und Onkologie.

[7]  Shamshad Ali,et al.  Radiation therapy with or without weekly cisplatin for bulky stage 1B cervical carcinoma: follow-up of a Gynecologic Oncology Group trial. , 2007, American journal of obstetrics and gynecology.

[8]  J. Debus,et al.  Severe Reversible Toxic Encephalopathy Induced by Cisplatin in a Patient with Cervical Carcinoma Receiving Combined Radiochemotherapy , 2007, Strahlentherapie und Onkologie.

[9]  C. De Wagter,et al.  Late radiotherapy-induced lower intestinal toxicity (RILIT) of intensity-modulated radiotherapy for prostate cancer: the need for adapting toxicity scales and the appearance of the sigmoid colon as co-responsible organ for lower intestinal toxicity. , 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[10]  J. Thigpen,et al.  Long-term follow-up of a randomized trial comparing concurrent single agent cisplatin, cisplatin-based combination chemotherapy, or hydroxyurea during pelvic irradiation for locally advanced cervical cancer: a Gynecologic Oncology Group Study. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  P. Viens,et al.  Contribution of surgery in patients with bulky residual disease after chemoradiation for advanced cervical carcinoma. , 2007, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[12]  Christian Kirisits,et al.  Clinical impact of MRI assisted dose volume adaptation and dose escalation in brachytherapy of locally advanced cervix cancer. , 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[13]  Miao-Fen Chen,et al.  Clinical outcome in posthysterectomy cervical cancer patients treated with concurrent Cisplatin and intensity-modulated pelvic radiotherapy: comparison with conventional radiotherapy. , 2007, International journal of radiation oncology, biology, physics.

[14]  C. De Wagter,et al.  Precautions and strategies in using a commercial flatbed scanner for radiochromic film dosimetry , 2007, Physics in medicine and biology.

[15]  D. Low.  Image-Guided IMRT , 2006, Medical physics.

[16]  P. Morice,et al.  Surgery after concurrent chemoradiotherapy and brachytherapy for the treatment of advanced cervical cancer: morbidity and outcome: results of a multicenter study of the GCCLCC (Groupe des Chirurgiens de Centre de Lutte Contre le Cancer). , 2006, Gynecologic oncology.

[17]  D. Heron,et al.  Feasibility of concurrent cisplatin and extended field radiation therapy (EFRT) using intensity-modulated radiotherapy (IMRT) for carcinoma of the cervix. , 2006, Gynecologic oncology.

[18]  A. Fyles,et al.  Dosimetric comparison of intensity-modulated, conformal, and four-field pelvic radiotherapy boost plans for gynecologic cancer: a retrospective planning study , 2006, Radiation oncology.

[19]  C. McConkey,et al.  Improved survival after concurrent weekly cisplatin and radiotherapy for cervical carcinoma with assessment of acute and late side-effects. , 2006, Clinical oncology (Royal College of Radiologists (Great Britain)).

[20]  R. Reznek,et al.  Mapping pelvic lymph nodes: guidelines for delineation in intensity-modulated radiotherapy. , 2005, International journal of radiation oncology, biology, physics.

[21]  Neeta Pandit-Taskar,et al.  Oncologic imaging in gynecologic malignancies. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[22]  C. De Wagter,et al.  An inter-centre quality assurance network for IMRT verification: results of the ESTRO QUASIMODO project. , 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[23]  Branislav Jeremic,et al.  Positron Emission Tomography for Radiation Treatment Planning , 2005, Strahlentherapie und Onkologie.

[24]  J. Tierney,et al.  Concomitant chemotherapy and radiation therapy for cancer of the uterine cervix. , 2005, The Cochrane database of systematic reviews.

[25]  Filip Claus,et al.  Interobserver Delineation Variation Using CT versus Combined CT + MRI in Intensity–Modulated Radiotherapy for Prostate Cancer , 2005, Strahlentherapie und Onkologie.

[26]  B. Erickson,et al.  Simultaneous integrated intensity-modulated radiotherapy boost for locally advanced gynecological cancer: radiobiological and dosimetric considerations. , 2005, International journal of radiation oncology, biology, physics.

[27]  W. D'Souza,et al.  Feasibility of dose escalation using intensity-modulated radiotherapy in posthysterectomy cervical carcinoma. , 2005, International journal of radiation oncology, biology, physics.

[28]  Eugene Wong,et al.  Intensity-modulated arc therapy for treatment of high-risk endometrial malignancies. , 2005, International journal of radiation oncology, biology, physics.

[29]  Peter Smeets,et al.  Clinical implementation of intensity-modulated arc therapy (IMAT) for rectal cancer. , 2004, International journal of radiation oncology, biology, physics.

[30]  M. Johnston,et al.  Concurrent cisplatin-based chemotherapy plus radiotherapy for cervical cancer: a meta-analysis. , 2004, Clinical oncology (Royal College of Radiologists (Great Britain)).

[31]  Y. D. Deene,et al.  Validation and application of polymer gel dosimetry for the dose verification of an intensity-modulated arc therapy (IMAT) treatment. , 2004, Physics in medicine and biology.

[32]  E. D. de Vries,et al.  Acute and long-term toxicity following radiotherapy alone or in combination with chemotherapy for locally advanced cervical cancer. , 2003, Cancer treatment reviews.

[33]  Werner De Gersem,et al.  Whole abdominopelvic radiotherapy (WAPRT) using intensity-modulated arc therapy (IMAT): first clinical experience. , 2003, International journal of radiation oncology, biology, physics.

[34]  J. Tierney,et al.  A systematic review of acute and late toxicity of concomitant chemoradiation for cervical cancer. , 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[35]  M. Rotman,et al.  Radiation therapy with and without extrafascial hysterectomy for bulky stage IB cervical carcinoma: a randomized trial of the Gynecologic Oncology Group. , 2003, Gynecologic oncology.

[36]  W. De Gersem,et al.  Dose conformation in IMRT for head and neck tumors: which solution to apply? , 2002, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

[37]  R. Mohan,et al.  Clinical application of intensity-modulated radiotherapy for locally advanced cervical cancer. , 2002, Seminars in radiation oncology.

[38]  John C Roeske,et al.  Intensity-modulated whole pelvic radiotherapy in women with gynecologic malignancies. , 2002, International journal of radiation oncology, biology, physics.

[39]  W. De Gersem,et al.  Leaf position optimization for step-and-shoot IMRT. , 2001, International journal of radiation oncology, biology, physics.

[40]  D Low,et al.  Intensity-modulated radiation therapy (IMRT) reduces small bowel, rectum, and bladder doses in patients with cervical cancer receiving pelvic and para-aortic irradiation. , 2001, International journal of radiation oncology, biology, physics.

[41]  V. Valentini,et al.  Phase I-II trial of preoperative chemoradiation in locally advanced cervical carcinoma. , 2000, Gynecologic oncology.

[42]  P. Grigsby,et al.  Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[43]  B. Goff,et al.  The prognostic significance of radiation dose and residual tumor in the treatment of barrel-shaped endophytic cervical carcinoma. , 2000, Gynecologic oncology.

[44]  B N Bundy,et al.  Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[45]  P J Eifel,et al.  Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. , 1999, The New England journal of medicine.

[46]  B N Bundy,et al.  Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. , 1999, The New England journal of medicine.

[47]  D. Low,et al.  A technique for the quantitative evaluation of dose distributions. , 1998, Medical physics.

[48]  P. Carroll,et al.  The response of the urinary bladder, urethra, and ureter to radiation and chemotherapy. , 1995, International journal of radiation oncology, biology, physics.

[49]  M. Gamerre,et al.  Concomitant chemoradiation prior to surgery in the treatment of advanced cervical carcinoma. , 1994, Gynecologic oncology.

[50]  J. Sham,et al.  Dose-tumor response of carcinoma of cervix: an analysis of 594 patients treated by radiotherapy. , 1993, Gynecologic oncology.

[51]  M. Goitein,et al.  Tolerance of normal tissue to therapeutic irradiation. , 1991, International journal of radiation oncology, biology, physics.

[52]  H. Kuramoto,et al.  Optimal dose for stage IIIB adenocarcinoma of the uterine cervix on the basis of biological effective dose. , 2006, European journal of gynaecological oncology.

[53]  C. Wagter.  QA-QC of IMRT: European Perspective , 2006 .

[54]  G E Hanks,et al.  Tumor and treatment factors improving outcome in stage III-B cervix cancer. , 1991, International journal of radiation oncology, biology, physics.